Shares of Bristol Myers BMY continue to lose momentum in 2025. In fact, the stock lost 4.7% in a month against the industry’s gain of 4.8%. Consequently, the stock slipped below its 50-day simple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback